A Hollywood physician could lose his medical license after recommending that a father give his 4-year-old son marijuana cookies to control temper tantrums, according to California’s medical board.
Dr. William Eidelman, a natural medicine physician, improperly diagnosed the boy with attention deficit hyperactivity disorder and bipolar disorder before recommending marijuana as the treatment, the medical board said in a decision announced last month.
The board ordered the doctor’s license revoked as of Jan. 4. However, his lawyers say a judge stayed the order so his license is active and he continues to practice.
The penalties against Eidelman stem from his treatment of a young boy who was misbehaving in school and brought to the doctor’s office by his father in September 2012, according to the medical board report.
Much of Eidelman’s practice centers on writing letters for patients to obtain medical marijuana, which he said he began doing in 1997, shortly after the state first legalized the drug for medical use.
After a 30-minute visit with the boy and his father, the doctor wrote in his chart that the child had a “probable combination of ADD/ADHD and bipolar disorder” and should “try cannabis in small amounts in cookies,” according to the medical board’s decision.
The boy appeared nervous and agitated but not “abnormal,” according to an interview with the doctor that was included in medical board documents. [Read More @ LA Times]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
The Mississippi law that will legalize medical marijuana goes into effect tomorrow, and farmers will then be allowed to start crop production. But experts say it will take some time before patients can purchase product. This Friday, dozens of laws will go into effect, including the Mississippi Medicinal Cannabis Trade act. The bill was signed…
Whitepaper This compaction study examines the effects of choice in carrier materials on CBD/THC tablet compressibility, powder flow, particle size and distribution, and moisture content. Natoli Scientific studied the mechanical robustness and failure points of these solid oral dose tablets using rigorous powder micromeritics and compaction profile studies. An exact science-based approach allows manufacturers to…
The California Assembly Wednesday night voted 66-0 in favor of AB195, a trailer bill containing a slew of measures intended to shore up the state’s ailing cannabis industry, including freezing the state excise tax at 15 percent for 3 years, and suspending the cultivation tax beginning January 1, 2023 – with July 1, 2022 the…
PRESS RELEASE June 28, 2022 – The Association of Food and Drug Officials (AFDO) and Foundation of Cannabis United Standards (FOCUS) have officially launched efforts to develop a Federal Regulatory Framework, or FRF, for cannabis in the U.S. “Federal involvement and regulatory oversight of the U.S. cannabis industry is imperative to the health and safety…